Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)
Lefevre, Jérémie H, Mineur, Laurent, Kotti, Salma, Rullier, Eric, Rouanet, Philippe, de Chaisemartin, Cécile, Meunier, Bernard, Mehrdad, Jafari, Cotte, Eddy, Desrame, Jérome, Karoui, Mehdi, Benoist, Stéphane, Kirzin, Sylvain, Berger, Anne, Panis, Yves, Piessen, Guillaume, Saudemont, Alain, Prudhomme, Michel, Peschaud, Frédérique, Dubois, Anne, Loriau, Jérome, Tuech, Jean-Jacques, Meurette, Guillaume, Lupinacci, Renato, Goasgen, Nicolas, Parc, Yann, Simon, Tabassome, Tiret, Emmanuel
Published in Journal of clinical oncology (01.11.2016)
Published in Journal of clinical oncology (01.11.2016)
Get full text
Journal Article
Second‐line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine‐platinum combination: A large multicenter study by the Association des Gastro‐Entérologues Oncologues
Brieau, Bertrand, Dahan, Laetitia, De Rycke, Yann, Boussaha, Tarek, Vasseur, Philippe, Tougeron, David, Lecomte, Thierry, Coriat, Romain, Bachet, Jean‐Baptiste, Claudez, Pierre, Zaanan, Aziz, Soibinet, Pauline, Desrame, Jérome, Thirot‐Bidault, Anne, Trouilloud, Isabelle, Mary, Florence, Marthey, Lysiane, Taieb, Julien, Cacheux, Wulfran, Lièvre, Astrid
Published in Cancer (15.09.2015)
Published in Cancer (15.09.2015)
Get full text
Journal Article
Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study
Williet, Nicolas, Saint, Angélique, Pointet, Anne-Laure, Tougeron, David, Pernot, Simon, Pozet, Astrid, Bechade, Dominique, Trouilloud, Isabelle, Lourenco, Nelson, Hautefeuille, Vincent, Locher, Christophe, Desrame, Jérome, Artru, Pascal, Thirot Bidault, Anne, Le Roy, Bertrand, Pezet, Denis, Phelip, Jean-Marc, Taieb, Julien
Published in Therapeutic advances in gastroenterology (2019)
Published in Therapeutic advances in gastroenterology (2019)
Get full text
Journal Article
Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter Trial
Lefèvre, Jérémie H, Mineur, Laurent, Cachanado, Marine, Denost, Quentin, Rouanet, Philippe, de Chaisemartin, Cécile, Meunier, Bernard, Mehrdad, Jafari, Cotte, Eddy, Desrame, Jérome, Karoui, Mehdi, Benoist, Stéphane, Kirzin, Sylvain, Berger, Anne, Panis, Yves, Piessen, Guillaume, Saudemont, Alain, Prudhomme, Michel, Peschaud, Frédérique, Dubois, Anne, Loriau, Jérome, Tuech, Jean-Jacques, Meurette, Guillaume, Lupinacci, Renato, Goasguen, Nicolas, Creavin, Ben, Simon, Tabassome, Parc, Yann
Published in Annals of surgery (01.11.2019)
Published in Annals of surgery (01.11.2019)
Get more information
Journal Article
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study
André, Thierry, Tougeron, David, Piessen, Guillaume, de la Fouchardière, Christelle, Louvet, Christophe, Adenis, Antoine, Jary, Marine, Tournigand, Christophe, Aparicio, Thomas, Desrame, Jérôme, Lièvre, Astrid, Garcia-Larnicol, Marie-Line, Pudlarz, Thomas, Cohen, Romain, Memmi, Salomé, Vernerey, Dewi, Henriques, Julie, Lefevre, Jérémie H, Svrcek, Magali
Published in Journal of clinical oncology (10.01.2023)
Published in Journal of clinical oncology (10.01.2023)
Get full text
Journal Article
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial
André, Thierry, Vernerey, Dewi, Mineur, Laurent, Bennouna, Jaafar, Desrame, Jérôme, Faroux, Roger, Fratte, Serge, Hug de Larauze, Marine, Paget-Bailly, Sophie, Chibaudel, Benoist, Bez, Jeremie, Dauba, Jérôme, Louvet, Christophe, Lepere, Céline, Dupuis, Olivier, Becouarn, Yves, Mabro, May, Egreteau, Joëlle, Bouche, Olivier, Deplanque, Gaël, Ychou, Marc, Galais, Marie Pierre, Ghiringhelli, François, Dourthe, Louis Marie, Bachet, Jean-Baptiste, Khalil, Ahmed, Bonnetain, Franck, de Gramont, Aimery, Taieb, Julien
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
Kim, Stefano, François, Eric, André, Thierry, Samalin, Emmanuelle, Jary, Marine, El Hajbi, Farid, Baba-Hamed, Nabil, Pernot, Simon, Kaminsky, Marie-Christine, Bouché, Olivier, Desrame, Jérôme, Zoubir, Mustapha, Ghiringhelli, François, Parzy, Aurélie, De La Fouchardiere, Christelle, Smith, Denis, Deberne, Mélanie, Spehner, Laurie, Badet, Nicolas, Adotevi, Olivier, Anota, Amélie, Meurisse, Aurélia, Vernerey, Dewi, Taieb, Julien, Vendrely, Véronique, Buecher, Bruno, Borg, Christophe
Published in The lancet oncology (01.08.2018)
Published in The lancet oncology (01.08.2018)
Get full text
Journal Article
Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III study
Phelip, Jean-Marc, Edeline, Julien, Blanc, Jean-Frédéric, Barbier, Emilie, Michel, Pierre, Bourgeois, Vincent, Neuzillet, Cindy, Malka, David, Manfredi, Sylvain, Desrame, Jérôme
Published in Digestive and liver disease (01.02.2019)
Published in Digestive and liver disease (01.02.2019)
Get full text
Journal Article
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France Trial
Taieb, Julien, Taly, Valérie, Henriques, Julie, Bourreau, Camille, Mineur, Laurent, Bennouna, Jaafar, Desrame, Jérôme, Louvet, Christophe, Lepere, Céline, Mabro, May, Egreteau, Joëlle, Bouche, Olivier, Mulot, Claire, Hormigos, Katia, Chaba, Kariman, Mazard, Thibault, de Gramont, Aimery, Vernerey, Dewi, André, Thierry, Laurent-Puig, Pierre
Published in Clinical cancer research (15.10.2021)
Published in Clinical cancer research (15.10.2021)
Get full text
Journal Article
Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study
Phelip, Jean Marc, Desrame, Jérôme, Edeline, Julien, Barbier, Emilie, Terrebonne, Eric, Michel, Pierre, Perrier, Hervé, Dahan, Laetitia, Bourgeois, Vincent, Akouz, Faiza Khemissa, Soularue, Emilie, Ly, Valérie Lebrun, Molin, Yann, Lecomte, Thierry, Ghiringhelli, François, Coriat, Romain, Louafi, Samy, Neuzillet, Cindy, Manfredi, Sylvain, Malka, David
Published in Journal of clinical oncology (20.01.2022)
Published in Journal of clinical oncology (20.01.2022)
Get full text
Journal Article
Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in patients (pts) with localized microsatellite instability-high (MSI)/mismatch repair deficient (dMMR) oeso-gastric adenocarcinoma (OGA): The GERCOR NEONIPIGA phase II study
Andre, Thierry, Tougeron, David, Piessen, Guillaume, De La Fouchardiere, Christelle, Louvet, Christophe, Adenis, Antoine, Jary, Marine, Tournigand, Christophe, Aparicio, Thomas, Desrame, Jérôme, Lièvre, Astrid, Garcia-Larnicol, Marie-Line, Pudlarz, Thomas, Henriques, Julie, Cohen, Romain, Lefevre, Jérémie, Svrcek, Magali
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma
McLellan, Paul, Henriques, Julie, Ksontini, Feryel, Doat, Solène, Hammel, Pascal, Desrame, Jérome, Trouilloud, Isabelle, Louvet, Christophe, Pietrasz, Daniel, Vernerey, Dewi, Bachet, Jean-Baptiste
Published in Clinics and research in hepatology and gastroenterology (01.05.2021)
Published in Clinics and research in hepatology and gastroenterology (01.05.2021)
Get full text
Journal Article
Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study
Pointet, Anne-Laure, Tougeron, David, Pernot, Simon, Pozet, Astrid, Béchade, Dominique, Trouilloud, Isabelle, Lourenco, Nelson, Hautefeuille, Vincent, Locher, Christophe, Williet, Nicolas, Desrame, Jérôme, Artru, Pascal, Soularue, Emilie, Le Roy, Bertrand, Taieb, Julien
Published in Clinics and research in hepatology and gastroenterology (01.06.2020)
Published in Clinics and research in hepatology and gastroenterology (01.06.2020)
Get full text
Journal Article
DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study
Kim, Stefano, Vendrely, Véronique, Saint, Angélique, André, Thierry, Vaflard, Pauline, Samalin, Emmanuelle, Pernot, Simon, Bouché, Oliver, Zubir, Mustapha, Desrame, Jérôme, de la Fouchardière, Christelle, Smith, Denis, Ghiringhelli, François, Vienot, Angélique, Jacquin, Marion, Klajer, Elodie, Nguyen, Thierry, François, Éric, Taieb, Julien, Le Malicot, Karine, Vernerey, Dewi, Meurisse, Aurélia, Borg, Christophe
Published in Experimental hematology & oncology (21.07.2023)
Published in Experimental hematology & oncology (21.07.2023)
Get full text
Journal Article
Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II study
Randrian, Violaine, Adenis, Antoine, Desrame, Jérôme, Barbier, Emilie, Di Fiore, Frédéric, Lièvre, Astrid, Dahan, Laetitia, Laurent-Puig, Pierre, Mineur, Laurent, Breysacher, Gilles, Roquin, Guillaume, Louafi, Samy, Lopez, Anthony, Louvet, Christophe, Borg, Christophe, Metges, Jean Philippe, Faroux, Roger, Gaba, Lila, Manfredi, Sylvain, Tougeron, David
Published in Digestive and liver disease (01.03.2020)
Published in Digestive and liver disease (01.03.2020)
Get full text
Journal Article
Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302)
Lapeyre-Prost, Alexandra, Pernot, Simon, Sigrand, Julie, Le Malicot, Karine, Mary, Florence, Aparicio, Thomas, Dahan, Laetitia, Caroli-Bosc, François-Xavier, Lecomte, Thierry, Doat, Solène, Marthey, Lysianne, Desrame, Jérôme, Lepage, Come, Taieb, Julien
Published in Clinical colorectal cancer (01.12.2020)
Published in Clinical colorectal cancer (01.12.2020)
Get full text
Journal Article
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma
Kim, Stefano, Meurisse, Aurélia, Spehner, Laurie, Stouvenot, Morgane, François, Eric, Buecher, Bruno, André, Thierry, Samalin, Emmanuelle, Jary, Marine, Nguyen, Thierry, El Hajbi, Farid, Baba-Hamed, Nabil, Pernot, Simon, Kaminsky, Marie-Christine, Bouché, Olivier, Desrame, Jerome, Zoubir, Mustapha, Ghiringhelli, François, Parzy, Aurélie, de la Fouchardiere, Christelle, Boulbair, Fatiha, Lakkis, Zaher, Klajer, Elodie, Jacquin, Marion, Taieb, Julien, Vendrely, Véronique, Vernerey, Dewi, Borg, Christophe
Published in Therapeutic advances in medical oncology (2020)
Published in Therapeutic advances in medical oncology (2020)
Get full text
Journal Article
Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial
Pernot, Simon, Artru, Pascal, Mithieux, François, Marsot, Julien, Watkin, Emmanuel, Pellerin, Olivier, Lledo, Gerard, Chalabreysse, Philippe, Desramé, Jérome, Taieb, Julien
Published in Clinics and research in hepatology and gastroenterology (01.12.2015)
Published in Clinics and research in hepatology and gastroenterology (01.12.2015)
Get full text
Journal Article
PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer
Evrard, Camille, Louvet, Christophe, Hajbi, Farid EL, Fiore, Frédéric DI, Malicot, Karine LE, Aparicio, Thomas, Bouché, Olivier, Laurent-Puig, Pierre, Bibeau, Frédéric, Lecomte, Thierry, Lièvre, Astrid, Guimbaud, Rosine, Kim, Stefano, Zaanan, Aziz, Sokol, Harry, Chibaudel, Benoist, Desrame, Jérome, Pierre, Sabrina, Gonzalez, Daniel, Lepage, Come, Tougeron, David
Published in Digestive and liver disease (01.04.2021)
Published in Digestive and liver disease (01.04.2021)
Get full text
Journal Article